Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study
- 3 July 2013
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 28 (7) , 541-550
Abstract
There is strong evidence from observational studies suggesting serum C-reactive protein (CRP) is associated with cardiovascular and all-cause mortality. However, less is known about whether there are differences in the association of CRP with all-cause or cause specific mortality by sex, smoking, body mass index (BMI), or physical activity. We aimed to investigate these interactions and also investigate and compare the association of CRP and other inflammation markers (i.e., fibrinogen and leukocyte count) with all-cause and cause-specific mortality. Men and women aged 40–79 were recruited in 1993–1997 in the EPIC-Norfolk cohort study. A total of 16,850 participants with high-sensitivity assayed CRP data who had no known cancer, myocardial infarction and stroke at baseline were entered in the analysis to test the association of CRP, fibrinogen and leukocyte count with risk of all-cause and cause specific mortality. A total of, 2,603 all-cause deaths (1,452 in men) including 823 cardiovascular and 1,035 cancer deaths, were observed after 231,000 person-years of follow-up (median 14.3 years). CRP was positively associated with risk of all-cause, cardiovascular, and non-cancer non-cardiovascular mortality independent of established risk factors. The hazard ratio of all-cause mortality (95 % CI) for participants with CRP in the range of 3–10 and >10 mg/l (vs. <0.5 mg/l) was 1.56 (1.26–1.93) and 1.87 (1.43–2.43) respectively in men and 1.34 (1.07–1.68) and 1.98 (1.50–2.63) in women. The association was less positively graded in women with the increased risk being significant only at higher levels of the CRP distribution. The association persisted in never smokers and did not vary by levels of BMI or physical activity. Although fibrinogen and leukocyte count were also positively associated with mortality risk, only CRP remained a significant predictor of mortality when the inflammation markers were adjusted for one another in multivariable models. Serum CRP levels were a long-term predictor of risk of cardiovascular and non-cardiovascular mortality independent of known risk factors, fibrinogen, and leukocyte count.Keywords
This publication has 52 references indexed in Scilit:
- Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volumeJournal of Neurology, 2011
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and womenEuropean Heart Journal, 2009
- Physical Activity, White Blood Cell Count, and Lung Cancer Risk in a Prospective Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2008
- Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseasesFrontiers in Neuroendocrinology, 2008
- Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies CollaborationAmerican Journal of Epidemiology, 2007
- White Blood Cell Count and Mortality in the Baltimore Longitudinal Study of AgingJACC, 2007
- C-Reactive Protein Levels, Variation in the C-Reactive Protein Gene, and Cancer Risk: The Rotterdam StudyJournal of Clinical Oncology, 2006
- Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition CohortCancer Epidemiology, Biomarkers & Prevention, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004